title: [The effect of sodium phenylbutyrate to agents used in induction chemotherapy on laryngeal carcinoma cells Hep-2 in vitro].
abstract: OBJECTIVE
  To study the effect of sodium phenylbutyrate when it combined with agents used in induction chemotherapy on laryngeal carcinoma cells Hep-2 in vitro.
  
  
  METHODS
  MTT were used to examine the growth inhibition of Hep-2 cells treated by the combination of PB with 5-FU or CDDP in vitro.
  
  
  RESULTS
  When 5-FU or CDDP combined with PB respectively, there was significantly difference between every two dose groups of the two agents or every dose group and control group ( P < 0.05). When the dosage of 5-FU or CDDP was definition,there was significantly difference between every two dose groups of PB ( P < 0.05).
  
  
  CONCLUSIONS
  PB could enhance the cytotoxic effects of agents used in induction chemotherapy on laryngeal carcinoma cells Hep-2 in vitro, which showed the possibility in reinforcement the treatment effect and reduction the occurrence of the complication and toxic reaction of induction chemotherapy on laryngeal carcinoma.
authors.affiliation: Department of Otolaryngology, Qilu Hospital of Shandong University, Jinan, 250012, China. gjdzb@126.com
authors.forename: Jing
authors.initials: J
authors.lastname: Gao
authors.forename: Xinyong
authors.initials: X
authors.lastname: Ruan
authors.forename: Xinliang
authors.initials: X
authors.lastname: Pan
authors.forename: Fenglei
authors.initials: F
authors.lastname: Xu
authors.forename: Dapeng
authors.initials: D
authors.lastname: Lei
authors.forename: Dayu
authors.initials: D
authors.lastname: Liu
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D002277:Carcinoma / Q000188:drug therapy* / Q000473:pathology; D002453:Cell Cycle / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D006801:Humans; D007822:Laryngeal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D010654:Phenylbutyrates / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D010654:Phenylbutyrates